Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Erb-196 is an estrogen receptor-receptor agonist with non-steroidal selectivity.
Description | Erb-196 is an estrogen receptor-receptor agonist with non-steroidal selectivity. |
In vivo | ERB-196 significantly reduces histopathologic evidence of injury to the gastrointestinal mucosal surface (0.7±0.1 vs. 2.3±0.2 for control;?p<0.05).?The mucosal mass of 10-cm segments of small bowel mucosa shows better preservation of mucosal mass than control treatment (63±20 [ERB-196] vs. 31±24 [control]), but this difference fails to reach statistical significance (p<0.06).?The administration of ERB-196 is highly effective in the prevention of lethality.?Consistent with the neutropenic rat model, ERB-196 significantly increases survival when compare with vehicle control. |
Synonyms | WAY-202196 |
Molecular Weight | 279.27 |
Formula | C17H10FNO2 |
CAS No. | 550997-55-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ERB-196 550997-55-2 Endocrinology/Hormones Estrogen/progestogen Receptor WAY-202196 ERB 196 WAY202196 ERB196 WAY 202196 inhibitor inhibit